10:00 AM EST - Fennec Pharmaceuticals Inc. : Will release its second-quarter 2025 financial results before the opening of the U.S. financial markets on Thursday, August 14. Management will host a conference call and webcast that day to discuss the Company’s financial and business results. Fennec Pharmaceuticals Inc.
shares T.FEC are trading unchanged at $6.14.
